|
| Article Authors: | Peter Hoogerhout; Willem Kamphuis; Humphrey F Brugghe; Jacqueline A Sluijs; Hans A M Timmermans; Janny Westdijk; Gijsbert Zomer; Claire J P Boog; Elly M Hol; Germie P J M van den Dobbelsteen |
|---|
| Article Title: | A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques. |
|---|
|
| Reference ID: | 1021989 |
|---|
| Abstract: | The 39- to 42-residue amyloid β (Aβ) peptide is deposited in extracellular fibrillar plaques in the brain of patients suffering from Alzheimer's Disease (AD). Vaccination with these peptides seems to be a promising approach to reduce the plaque load but results in a dominant antibody response directed against the N-terminus. Antibodies against the N-terminus will capture Aβ immediately after normal physiological processing of the amyloid precursor protein and therefore will also reduce the levels of non-misfolded Aβ, which might have a physiologically relevant function. Therefore, we have targeted an immune response on a conformational neo-epitope in misfolded amyloid that is formed in advance of Aβ-aggregation. A tetanus toxoid-conjugate of the 11-meric cyclic peptide Aβ(22-28)-YNGK' elicited specific antibodies in Balb/c mice. These antibodies bound strongly to the homologous cyclic peptide-bovine serum albumin conjugate, but not to the homologous linear peptide-conjugate, as detected in vitro by enzyme-linked immunosorbent assay. The antibodies also bound--although more weakly--to Aβ(1-42) oligomers as well as fibrils in this assay. Finally, the antibodies recognized Aβ deposits in AD mouse and human brain tissue as established by immunohistological staining. We propose that the cyclic peptide conjugate might provide a lead towards a vaccine that could be administered before the onset of AD symptoms. Further investigation of this hypothesis requires immunization of transgenic AD model mice. |
|---|
| Affiliations: | Department of Vaccinology, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Peter.Hoogerhout@rivm.nl |
|---|
| Date: | 2011 |
|---|
| Reference Type: | Literature |
|---|
| PubMed ID: | 21526148 |
|---|
| Journal: | PLoS ONE |
|---|
| Journal Volume: | 6 |
|---|
| Article Pages: | e19110 |
|---|
| Journal ISSN: | 1932-6203 |
|---|
| Article Chemical List: | Amyloid beta-Peptides;Antibodies;Antigens;Peptides, Cyclic |
|---|
| Article MeSH List: | Alzheimer Disease(immunology); Amino Acid Sequence; Amyloid beta-Peptides(chemistry; immunology); Animals; Antibodies(immunology); Antigens(immunology); Blotting, Western; Brain(pathology); Enzyme-Linked Immunosorbent Assay; Humans; Immunization; Immunohistochemistry; Mice; Molecular Sequence Data; Peptides, Cyclic(chemistry; immunology); Plaque, Amyloid(immunology); Protein Structure, Quaternary; Protein Structure, Secondary |
|---|
| Curation Last Updated: | 2012-05-31 20:50:08 |
|---|
